2nd Quarter - Report
HOLLAND & KNIGHT LLP for LIFECELL CORPORATION
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1984, Breast Cancer Patient Education Act of 2013 and its companion bill in the Senate, S.931; Medicare coverage and payment policy for chronic complex diseases.
Foreign entity interest: As the private equity owners of LifeCell Corporation, the interests of Chiron B1 S.a.r.l. Luxembourg, CPP Investments Board Private Holdings, Inc., and Port-Aux-Choix Private Investments, Inc., identified on form LD-1, are aligned with those of LifeCell Corporation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL S. BOCK | — |
| JIM DAVIS | — |
| MIRANDA FRANCO | — |
| MICHAEL M GABA | — |
| KARL KOCH | — |
| KATHRYN H LEHMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.